- DocumentoCDC Lab 2016 - Hepatitis Testing A-Ecaricato daRobert G. Gish, MD
- DocumentoHepatitis C virus as a systemic diseasecaricato daRobert G. Gish, MD
- DocumentoCost of Curing HCVcaricato daRobert G. Gish, MD
- DocumentoLetter to MHPA Jeff Myerscaricato daRobert G. Gish, MD
- DocumentoCost Effectiveness and Budget Impact of Treating HCVcaricato daRobert G. Gish, MD
- DocumentoHepatitis C Rallies In San Franciscocaricato daRobert G. Gish, MD
- DocumentoCenters for Medicare & Medicaid Services Letter to Statescaricato daRobert G. Gish, MD
- DocumentoHepatitis C Policy California Medicaidcaricato daRobert G. Gish, MD
- DocumentoStanford Clinic in Sacramentocaricato daRobert G. Gish, MD
- DocumentoStanford Clinic in San Franciscocaricato daRobert G. Gish, MD
- DocumentoCME Conferencecaricato daRobert G. Gish, MD
- DocumentoPresentation at the 2015 Liver Summitcaricato daRobert G. Gish, MD
- DocumentoPresentationcaricato daRobert G. Gish, MD
- DocumentoMessage from CEVHAPcaricato daRobert G. Gish, MD
- DocumentoArticlecaricato daRobert G. Gish, MD
- DocumentoConferencecaricato daRobert G. Gish, MD
- DocumentoArticle in The Journal of Medical Practice Managementcaricato daRobert G. Gish, MD
- DocumentoChanging Nomenclature for PBCcaricato daRobert G. Gish, MD
- DocumentoEventcaricato daRobert G. Gish, MD
- DocumentoCEVHAP Membership Application Formcaricato daRobert G. Gish, MD
- DocumentoCEVHAP Pamphletcaricato daRobert G. Gish, MD
- DocumentoUpdating Hepatitis B & C Prevalence Estimates in the U.S.caricato daRobert G. Gish, MD
- DocumentoAbnormal Liver Tests Presentationcaricato daRobert G. Gish, MD
- DocumentoHCV Policy Presentation 2015caricato daRobert G. Gish, MD
- DocumentoThe Hepatitis C Education and Support Group Assistance Programcaricato daRobert G. Gish, MD
- DocumentoDr. Gish Lecturecaricato daRobert G. Gish, MD
- DocumentoPress Releasecaricato daRobert G. Gish, MD
- DocumentoAdvisory Letter 2015caricato daRobert G. Gish, MD
- DocumentoGish_et_al-2015-Hepatology HBV HCV New Estimatescaricato daRobert G. Gish, MD
- DocumentoFinal Comments on Medicaid MCO Proposed Rulecaricato daRobert G. Gish, MD
- DocumentoPrimary Biliary Cirrhosis Has A New Name (Cholangitis)caricato daRobert G. Gish, MD
- DocumentoNVHR Urgency Fact Sheet_Two Pager Finalcaricato daRobert G. Gish, MD
- DocumentoNVHR Urgency Fact Sheet_One Pager Finalcaricato daRobert G. Gish, MD
- DocumentoPBC Name Clip Artcaricato daRobert G. Gish, MD
- DocumentoFrequency of elevated biomarkers in patients with cryptogenic hepatocellular carcinomacaricato daRobert G. Gish, MD
- DocumentoImproving Patient Access to Hepatitis C Curescaricato daRobert G. Gish, MD
- DocumentoChronic hepatitis Bcaricato daRobert G. Gish, MD
- DocumentoLetter to POTUS Re HCV Treatment Accesscaricato daRobert G. Gish, MD
- DocumentoStanford Liver Transplant and General Hepatology Outreach - Las Vegascaricato daRobert G. Gish, MD
- DocumentoStanford Liver Transplant and General Hepatology Outreach - San Franciscocaricato daRobert G. Gish, MD
- DocumentoStanford Liver Transplant and General Hepatology Outreachcaricato daRobert G. Gish, MD
- DocumentoNewslettercaricato daRobert G. Gish, MD
- DocumentoPredictors of hepatic decompensation after TACE for hepatocellular carcinomacaricato daRobert G. Gish, MD
- DocumentoSynthetic RNAi triggers and their use in chronic hepatitis B therapies with curative intentcaricato daRobert G. Gish, MD
- DocumentoJournal of Viral Hepatitis - Estimates on HCV disease burden worldwide– filling the gaps.caricato daRobert G. Gish, MD
- DocumentoPhysicians Update June-July 2015caricato daRobert G. Gish, MD
- DocumentoHCC Surveillance in an Era of Biomarkerscaricato daRobert G. Gish, MD
- DocumentoCenters for Medicare & Medicaid Services Request HBV Screeningcaricato daRobert G. Gish, MD
- DocumentoHBV QsAG is Ready for Prime Timecaricato daRobert G. Gish, MD